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Abstract 
It is generally recognized that calcium oxalate 
crystal formation in urine is induced by heterogeneous 
nucleation. However, there is no consensus as to the 
nature of the nucleation substrate. Evidence is provided 
in this paper that membranous cellular degradation prod-
ucts are the most likely candidates because they: (1) are 
ubiquitous in urine and urinary stones; (2) are found in 
close association with crystal deposits in the kidneys; 
and (3) can induce nucleation of crystals from a meta-
stable solution of calcium oxalate in vitro and metastable 
urine in vivo. 
Key Words: Calcium oxalate, nephrolithiasis, cell 
membrane, urolithiasis, matrix vesicles, mineralization, 
calcium phosphate. 
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Introduction 
An important event in the onset of urolithiasis is 
supersaturation of urine with a potentially precipitating 
crystalline phase; the greater the supersaturation, the 
greater the likelihood of precipitation [31]. Supersatu-
rated urine can be metastable or unstable. In an unstable 
solution, crystals form spontaneously by homogeneous 
nucleation. In a metastable solution, crystals may be in-
duced by a foreign interface such as certain macromole-
cules or other crystals that can act as nidi for crystal 
nucleation. Extremely high levels of supersaturation are 
necessary to produce homogeneous nucleation and it is 
highly unlikely that the spontaneous formation products 
of any of the stone salts will ever be attained in the 
urine. For example, homogeneous nucleation of calcium 
oxalate (CaOx) monohydrate does not dominate until 
relative supersaturation reaches 70 and CaOx relative 
supersaturation in mammalian urine rarely exceeds 30 
[19, 30, 31]. Moreover, since urine contains a number 
of macromolecules and cellular degradation products, it 
is most likely that the nucleation therein is heterogene-
ous. This thinking was reflected in the report of the 
1981 Dahlem Conference on Biological Mineralization 
and Demineralization [78] which concluded that (1) 
"homogeneous nucleation of any of the urinary stone 
salts or acids is unlikely", and (2) "nucleation of uri-
nary calculi is probably heterogeneous". United States 
National Institutes of Health Consensus Development 
Conference on Prevention and Treatment of Kidney 
Stones, held in March 1988 [79], also concluded that 
"disorders that raise supersaturation and promote 
heterogeneous nucleation are the presently accepted 
causes of nephrolithiasis". 
Crystals as Nucleators 
What are the substrates acting as heterogeneous nu-
cleators? Are they crystalline or macromolecular? Is 
there a specific substrate for a specific crystal type, or 
is heterogeneous nucleation simply a result of the pres-
ence of a foreign interface? Based upon the observa-
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tions that calcium phosphate (CaP) is the most common 
crystal in human urine [117), is ubiquitous in human uri-
nary stones, and is often seen at the center of the mixed 
CaOx/CaP urinary stones [84), nucleation of CaOx crys-
tals is proposed to be induced by CaP crystals. In addi-
tion, both apatite and brushite crystals have been shown 
to induce crystallization of CaOx in vitro from a meta-
stable solution of CaOx [76, 85). On the other hand, 
solubility of CaP is very sensitive to pH: it decreases 
with increasing pH [30, 90). Generally the apatite 
forms at higher, more alkaline pH, while brushite, at 
lower, more acidic pH. Even though brushite is not a 
common constituent of CaOx stones, suggestions have 
been made that brushite nucleates CaOx crystals and 
then transforms into apatite [30, 85). Most idiopathic 
CaOx stone formers neither have a highly alkaline nor 
acidic urine. In practice, lowering the urinary pH of 
CaOx stone formers by simple acidification did not re-
place apatite with brushite but resulted in the formation 
of purer CaOx stones [30, 90). 
Octacalcium phosphate, another crystal rarely en-
countered in kidney stones, has also been suggested to 
play a role in initiation of renal calculi. Recently 
Achilles et al. [1] grew spherulitic CaP in a gel matrix 
at 37°C from a supersaturated metastable solution con-
tinuously flowing over the gel surface. The spherulites 
contained a poorly crystalline core of amorphous carbon-
ate apatite surrounded by a well crystallized shell of ra-
dially oriented sheets of octacalcium phosphate. Subse-
quently CaOx monohydrate crystals were grown on these 
spherulites by continuously flowing a solution supersatu-
rated with respect to CaOx. Plate-like crystals of CaOx 
monohydrate demonstrated oriented growth in continua-
tion with the plate-like crystals of octacalcium phosphate 
indicating epitaxially mediated crystal nucleation. 
It has been demonstrated that even though excreted 
urine is generally supersaturated with respect to CaOx 
and CaP, the two crystallize and deposit at different lo-
cations in the kidneys [ 49, 55]. Calcium oxalate crystals 
generally deposit in collecting ducts of the renal papilla 
while calcium phosphate deposits in earlier segments of 
the nephron at the cortico-medullary junction. Data 
have been presented to support the hypothesis that urine 
becomes supersaturated with respect to calcium phos-
phate as early as the loop of Henle [21). In a recent 
study [73), crystallization was induced by standardized 
increments of calcium and oxalate in solutions with a 
composition corresponding to various segments of the 
nephron. Crystals of CaP were predominantly formed 
in solutions with composition corresponding to the urine 
in proximal tubules while CaOx crystals were formed in 
solutions with composition corresponding to the urine in 
the collecting ducts. Moreover, sex hormones appear to 
play an important role in nephrolithiasis. Kidneys of 
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male rats are prone to form calcium oxalate deposits 
while kidneys of female rats tend to form calcium phos-
phate [49). Sex hormone dependence of crystallization 
may be one reason why CaOx nephrolithiasis is more 
common in men while CaP nephrolithiasis is more com-
mon in women [84). Urine spends only a few minutes 
in the renal tubules, which is not enough time for single 
crystals of CaOx to grow large enough for their reten-
tion within the renal tubules [32). The formation of a 
nucleating CaP crystals, and then nucleation and growth 
of CaOx crystals, should take even longer making it 
more difficult for CaOx crystals to reach a size large 
enough for retention and development of a kidney stone. 
Recent studies have demonstrated that urinary crys-
tals of calcium-containing salts almost always have a 
macromolecular coating. Transmission electron micro-
scopic examination of urinary stones as well as other 
mineralized tissues has shown that demineralization re-
sults in replacement of crystals by crystal ghosts which 
represent the macromolecular coat [53, 54]. Thus, in 
the urinary environment, actual crystal surfaces may not 
be available for heterogeneous nucleation. CaP crystals 
in the renal fluid may not necessarily induce nucleation 
of Ca Ox in the kidneys just because CaP can act as het-
erogeneous nucleator of CaOx in vitro. If urinary crys-
tals do play a role in nucleation of other crystals, they 
most probably are involved through the adsorbed macro-
molecules. Macromolecules dissolved in solution often 
act as inhibitors of crystallization, but once adsorbed on 
a surface, they may promote crystallization [18). 
What about the presence of CaP crystals in CaOx 
stones, particularly the stone center? These CaP crystals 
may be adventitiously acquired by the CaOx stones and 
may simply represent crystalluria particles formed dur-
ing alkaline tides [90). Stone nidus may be formed by 
aggregation and retention of crystals [53] which later be-
come covered with a mantle of organic matrix material. 
Such a surface could provide a platform for further crys-
tal deposition similar to foreign body encrustation [52). 
Similarly, Randall's plaques, which are papillary calcifi-
cations, rich in organic material [92), might also act as 
encrustation platforms and become nidi for the formation 
of renal stones. Thus, a kidney stone with CaP in the 
center may originate with intratubular precipitation and 
retention of CaP crystals which become overgrown with 
CaOx monohydrate [46). 
In some in vitro studies, crystals of uric acid [39) 
and sodium acid urate [22, 86) have been shown to be 
able to induce heterogeneous nucleation of CaOx. Other 
studies, however, showed that uric acid crystals were 
not good nucleators of CaOx, and sodium acid urate 
crystals, though good nucleators, are generally not pre-
cipitated in the urine [33). On the other hand, evidence 
has been presented that dissolved urate, at normal 
Calcium oxalate crystals in mammalian urine 
physiological pH, can directly provoke CaOx crystal 
nucleation by the phenomenon of salting out [37, 98]. 
Growth of CaOx monohydrate on uric acid crystals may 
also be epitaxially mediated since CaOx monohydrate 
crystals grow on uric acid seeds in preferred orientation 
and CaOx monohydrate and uric acid form good atomic 
matches at the crystal surface [74]. 
Urinary Macromolecules as Nucleators 
Since all urinary stones contain an organic matrix 
which is intimately associated with the crystals and con-
sists essentially of the same proteins as the urine, it has 
long been suggested that urinary proteins are precursors 
of stone matrix and promoters of crystallization [13]. 
This subject has been recently discussed in an excellent 
review by Ryall and Stapleton [97]. Therefore, only the 
very pertinent elements will be addressed here. 
Early studies suggested that the most prominent anti-
genic content of stone matrix called matrix substance A, 
accounted for up to 85 % of its proteins [118]. It was 
reported to be present in the urine of stone patients, to 
originate from the renal parenchyma, and to be absent 
from the urine or the kidneys of normal individuals. 
This protein was suggested to be essential for the forma-
tion of urinary stones. However, the hypothesis that 
matrix substance A is involved in stone formation is 
weakened by the observations that this substance is pre-
sent in the urine of a variety of patients with renal injury 
[ 47], particularly those with infection of the urinary tract 
and is further undermined by results of later studies that 
showed that matrix substance A containing fraction of 
the stone matrix actually inhibited the growth of CaOx 
crystals in vitro [34]. 
Tamm-Horsfall protein/uromucoid complex, present 
both in urinary stone matrix and urine [118], is another 
substance suggested to be a promoter of crystallization 
of CaP as well as CaOx by providing nidi for their het-
erogeneous nucleation. Boyce et al. [15] studied in vitro 
crystallization of CaP in the presence of uromucoid de-
rived from normal urine and showed the amount of pre-
cipitate formed to be proportional to the concentration of 
uromucoid. In recent years, Rose and Sulaiman [95, 96] 
studied the role of Tamm-Horsfall protein (THP) and 
uromucoids on the crystallization of CaP and CaOx and 
showed that polymerized and aggregated Tamm-Horsfall 
protein acts as a promotor. For their studies, they rapi-
dly evaporated crystal-free urine at 37°C on a rotary 
evaporator to 1250 mosmol/kg and found that the re-
moval of macromolecules from the urine by ultrafiltra-
tion reduced the amount of precipitate formed and that 
this reduction was largely abolished by addition of physi-
ological quantities of Tamm-Horsfall protein. A number 
of workers in the field have been unable to confirm the 
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promotive role of the urinary protein; actually, they 
have found the THP/uromucoids to be inhibitors of 
CaOx and uric acid crystallization [28, 36, 70, 99]. 
Most of the current research on role of THP in nephro-
lithiasis indicates that the significance of THP lies in its 
involvement in CaOx crystal aggregation and depends on 
THP viscosity and solubility [40, 41]. At low ionic 
strength and high pH, THP is a powerful crystal aggre-
gation inhibitor. Decreasing pH and increasing ionic 
strength, increase THP viscosity and its crystal aggrega-
tion inhibition potential [41]. High calcium lowers THP 
solubility and promotes crystal aggregation, while high 
citrate has the opposite effect. THP from severely re-
current CaOx stone patients appears abnormal. It dem-
onstrates increased polymerization and reduced solubili-
ty, and thus, less potential for inhibiting Ca Ox crystal 
aggregation. As with matrix substance A mentioned ear-
lier, the questions about Tamm-Horsfall's role in crystal-
lization are also not yet resolved. 
Many other macromolecules, having high affinity 
for calcium, have also been isolated from both urine and 
urinary stone matrix [94] and it has been shown that the 
urines of active CaOx stone formers have greater calci-
um binding capacity than those of non-stone formers or 
inactive stone formers [93]. A protein containing the 
calcium binding amino acid, gamma-carboxyglutamic 
acid, has been isolated from the urine of stone formers 
and matrix of calcium containing urinary stones [72]. It 
has been suggested that this protein may provide a sub-
strate for nucleation of calcium-containing crystals. In 
a similar vein, Pinto et al. [88] isolated a urinary protein 
from the urine of stone formers that binds calcium and 
phosphate and promotes CaOx precipitation. Resnick 
and associates [93, 110] demonstrated the presence of 
uronic acid containing calcium-binding macromolecules 
in the urine of non-infectious CaOx stone formers and 
postulated a role for such molecules in crystal nuclea-
tion. In an experimental model, Itatani et al. [45] in-
duced calcium containing stones by unilateral obstruction 
of ureters of rabbits, which normally have massive cal-
cite crystalluria without stone formation. They found 
increased uronic acid production by the stone forming 
kidneys and concluded that calcium binding sulfated acid 
glycosaminoglycans produced by the kidneys resulted in 
crystal aggregation and the development of stones. In a 
similar study, using the same rabbit model, Wakatsuki 
et al. [115], however, found an increase in non-acidic 
non-sulfated glycosaminoglycan, hyaluronate, in the 
stone forming kidneys. Moreover, urinary glycosamino-
glycans, particularly those precipitable with Alcian blue, 
are also considered powerful inhibitors of crystallization 
[100]. 
Some of the other urinary macromolecules involved 
in CaOx nephrolithiasis: nephrocalcin [77], uropontin 
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(osteopontin) [42, 102), uronic acid rich protein [4, 5), 
inter-alpha trypsin inhibitor [ 107), and urinary prothrom-
bin fragment 1 (crystal matrix protein) [23, 108, 109) 
have all been shown to be inhibitors of CaOx crystalli-
zation processes. 
From the above discussion it becomes apparent that 
even though it is highly probable that urinary macro-
molecules play a major role in crystal nucleation, no 
crystalline or macromolecular substrate has yet been 
clearly identified as a promoter. Most of the urinary or 
stone matrix macromolecules suggested or shown to be 
crystallization promoters by some, have been character-
ized by others as inhibitors of, or to have no effect on, 
crystallization. This leads to the following conclusions: 
(1) the same urinary macromolecules may have dual ef-
fects on crystallization: they may inhibit crystal nuclea-
tion but promote crystal growth or vice versa; (2) their 
inhibitory or promotional activity depends on the ambi-
ent conditions; (3) urinary macromolecules used in many 
studies are not single entities, but mixtures of various 
macromolecules which will influence crystallization dif-
ferently under different in vitro experimental conditions; 
and (4) promoters of nucleation are yet to be identified. 
It appears that in the case of promoters of crystallization 
in urine, all of the above may apply. Matrix substance 
A, uromucoids, glycosaminoglycans (GAGs), and alcian 
blue positive material (ABPM), are all complex entities. 
Macromolecules belonging to GAGs and ABPM are a 
heterogeneous group [100). There is a wide range in 
degree of sulfation and charge density of the various 
urinary GAGs: more highly sulfated GAGs appear to be 
associated with stone formers' urines. Heparin, which 
is not present in the urine but is one of the most highly 
charged species of all GAGs, is shown to be a potent in-
hibitor of CaOx crystallization in vitro. Alcian blue pre-
cipitable material is shown to be inhibitory to crystalliza-
tion and proposed to consist mainly of GAGs. But, it 
must be pointed out that alcian blue is not a specific pre-
cipitant of GAGs but can also precipitate RNA-like ma-
terial and other polyanions [100). RNA is a potent in-
hibitor of CaOx crystal aggregation in vitro [16, 100). 
Cellular Membranes and Calcific Diseases 
Since the nature of macromolecules involved in het-
erogeneous nucleation of calcific crystals in urine is un-
certain, studies from other pathological biomineralization 
systems may provide direction. According to the cur-
rent concepts, initial calcium phosphate deposition in a 
number of calcific diseases [3, 7, 8, 9, 10, 11) occurs 
on cellular membranes which are present at the calcifica-
tion site, either as the limiting membrane of the so-
called matrix vesicles or as cellular degradation prod-
ucts. For example, in medial sclerosis of the large ar-
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teries and in calcific disease of the aortic valve, electron 
microscopic studies have established that extracellular 
vesicles serve as the initial sites of apatite deposition 
[64, 67, 69). The same is true of atherosclerotic plaque 
formation [3]. Calcification of tumors is also associated 
with membranes [105). Intracellular membrane vesicles 
appeared to nucleate the apatite of psammoma bodies in 
ovarian tumors and Michaelis-Gutmann bodies in mala-
koplakia [2], and when calcifying human meningiomas 
were cultured in vitro, psammoma bodies arose in asso-
ciation with extracellular matrix vesicles [29). Extra-
cellular vesicles derived from degenerating neoplastic 
cells have also been shown to be involved in neoplastic 
calcinosis [65). In tympanosclerosis of the middle ear 
[75), matrix vesicles derived from fibroblastic cells were 
the initial site of apatite deposition. Calcification during 
apatitic osteoarthritis and calcifying tendinitis is also 
shown to be mediated by matrix vesicles. During pla-
cental calcification, calcium hydroxyapatite precipitates 
in association with extracellular membranous vesicles 
[111). Calcification of bioprosthetic heart valves, fabri-
cated from porcine aortic valves or bovine pericardium, 
which is the main cause of their failure, is also mem-
brane mediated [101). Initial nuclei of calcification are 
associated with cellular membrane fragments derived 
from pig cusp cells in the case of porcine valves and 
from connective tissue cells in the case of bovine peri-
cardium. Calcification of intrauterine devices also ap-
pears to be initiated by cellular membranous material 
that is deposited on the devices during their exposure to 
the uterine fluid [56). Dental plaque and calculus for-
mation is yet another example of calcification initiated 
by cellular membranes [3, 7, 9, 10, 106, 114). Mem-
branes of microorganisms present in the dental plaque 
nucleate calcium hydroxyapatite, and thus, initiate cal-
culus formation. 
One of the main reasons that cellular membranes act 
as specific nucleators of calcium phosphate is proposed 
to be the presence of lipids, and particularly, the acidic 
phospholipids therein [7, 9, 10, 43, 44, 106, 114, 119, 
120). Lipids have been demonstrated to be present, both 
histochemically and biochemically, at physiological as 
well as pathological calcification sites [9, 10, 11, 43, 44, 
81, 119, 120). Although lipids account for a relatively 
small proportion of the organic matrix of mineralized 
tissues; 7-14% of bone, 2-6% of dentin, 12-22% of 
newly mineralized enamel, approximately 9.6 % of sub-
mandibular salivary gland calculi, and 10.2 % of supra-
gingival calculi, they have been isolated from matrices 
of all types of such tissues [9, 10, 11, 43, 44, 81, 119, 
120). In vitro, membranes, acidic phospholipids, lipid 
extracts from various calcified tissues, and liposomes 
have been shown to initiate calcium phosphate formation 
from metastable solutions [25, 27, 82, 103, 104, 113). 
Calcium oxalate crystals in mammalian urine 
Based on a review of the literature on calcified tis-
sues, it can be concluded that cellular membranes and 
their lipids are intimately involved in both physiological 
and pathological calcifications. Several lines of evidence 
exist that point to a role for cellular membrane constitu-
ents in urolithiasis also. In a number of experimental 
studies of metastatic calcification of kidneys [116], non-
mitochondrial calcific deposits were either present in 
proximal tubular basement membrane in association with 
membranous outpouchings of the cell or in the apical 
vacuoles of the epithelial cells. In a rat model, intra-
nephronic calculosis caused by feeding purified diets is 
membrane-mediated [17, 80, 83]. Vesicles derived from 
the microvillous brush border of the proximal tubules 
provide the nidus for intratubular deposition of calcium 
phosphate. The deposits start in the lumens of segment 
I of the proximal tubule and travel down the nephron 
while at the same time accruing mass by laminar growth 
in which both membranous vesicles and mineral are in-
volved. Finally, these microliths become large enough 
to be retained at the junction of the proximal tubule and 
the loop of Henle. Mineral content of the microliths 
increases, with the result that they become much more 
compact and the laminated structure is finally lost. Ex-
perimentally induced intranephronic calculosis, resulting 
from magnesium deficiency, also results in the formation 
of microliths in the lumens of the proximal tubules [83] 
and is shown to be initiated by deposition of mineral in 
the apical vacuoles [ 17]. 
In the case of human urolithiasis, a number of renal 
stones start at the tips of the renal papillae on plaques 
called Randall's plaques [91, 92]. These plaques contain 
cellular degradation products and crystals of calcium 
phosphate. Stones formed on such plaques were once 
thought to be rare, but a recent study of five hundred 
spontaneously passed small stones collected in Spain by 
Cifuentes-Delatte [19] has shown that 142 (28.4%) of 
them contained nidi of necrotic material identifiable as 
calcified tips of the renal papillae, indicating that at least 
in these cases, the stones could have originated by 
heterogeneous nucleation of crystals on the membranous 
cellular degradation products. 
The crystal membrane interaction discussed above 
deals with the nucleation of calcium phosphate. Most 
urinary stones however, contain calcium oxalate. Are 
membranes and lipids involved in CaOx nucleation? 
The answer to this question is yes. The involvement 
may be direct or indirect. Indirectly, the membranes 
and lipids may initiate nucleation of CaP which could 
then act as a substrate for nucleation of CaOx. Mem-
branes could also be directly involved in CaOx crystal 
nucleation as suggested by experimental studies of CaOx 
urolithiasis in the rat performed in my laboratory [50, 
57, 58, 59] and by our in vitro studies that will be dis-
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cussed later. Experimental studies of CaOx urolithiasis 
induced in rats showed that irrespective of the method 
utilized, the nature of the hyperoxaluria inducing agent 
used, and the location of crystal formation within the 
urinary system, CaOx crystals were always found asso-
ciated with an eosinophilic, periodic acid-Schiff (PAS) 
and colloidal iron positive material [50, 51]. In PAS 
reaction, aldehyde groups created by periodic acid oxi-
dation are demonstrated by Schiff reagent. Most glyco-
proteins stain positive with PAS while acid mucopoly-
saccahrides stain positive with acidified solution of 
colloidal iron. 
Even when a foreign body was implanted in the uri-
nary bladder of hyperoxaluric rats, crystals did not nu-
cleate on the native foreign body but on the organic ma-
terial that coated the foreign body surface [52). Electron 
microscopic examination of CaOx crystalline deposits in 
male Sprague-Dawley rats identified the material associ-
ated with the crystals as cellular degradation products 
consisting mostly of membranes [50, 59). 
Cellular Membranes and Calcium Oxalate 
Crystallization in vivo 
Hyperoxaluria-associated crystallization 
Intraperitoneal injection of sodium oxalate to male 
Sprague-Dawley rats causes acute hyperoxaluria and al-
most instantaneous deposition of CaOx crystals in renal 
tubules. Crystal deposition starts in the tubules of renal 
cortex and eventually involves the renal medulla. Crys-
tallization is associated with injury to the renal epithe-
lium lining the tubules and is manifested by shedding of 
brush border membrane into the urine. Crystals are al-
most always found associated with vesicular, membra-
nous and fibrillar material [24, 50, 55, 59). Cytochemi-
cal staining suggests that calcium complexation with the 
membrane starts the process of CaOx crystal formation. 
Chronic administration of 0. 75 % ethylene glycol in 
drinking water to male Sprague-Dawley rats for at least 
two weeks results in renal deposition of CaOx crystals 
[48). The deposition begins in the tubules of the renal 
medulla, particularly those at the papillary tips. Renal 
cortex may eventually become involved. Luminal crys-
tals are invariably mixed with cellular degradation prod-
ucts (Fig. 1). Papillary tip stones contain cellular degra-
dation products aggregating with the crystals (Fig. 2). 
Membranuria in association with hyperoxaluria 
The association between crystals and cellular degra-
dation products described above could very well be a 
phenomenon secondary to the precipitation of CaOx 
crystals in the renal tubules. To improve our under-
standing of the role of membranes in crystallization of 
CaOx and formation of kidney stones, we conducted a 
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Figure 1. Ghosts of CaOx monohydrate crystals (C) 
present in the lumen of a renal papillary collecting duct 
of a rat with nephrolithiasis. Ghosts are surrounded by 
membranous vesicular cellular degradation products 
(arrows). 
-----------------------------
series of studies where low grade hyperoxaluria, inade-
quate to induce crystal deposition in the kidneys, was 
induced in association with membranuria. Membrane 
shedding was induced specifically from the proximal tu-
bular brush border since brush border membrane is, in 
many respects, similar to the membrane of matrix vesi-
cles which are widely regarded as the initial site of both 
physiological and pathological calcification [3, 9). Like 
the membrane of matrix vesicles, renal brush border 
membrane is rich in alkaline phosphatase activity, and 
has high levels of phosphatidyl serine, sphingomyelin 
and cholesterol [6]. Alkaline phosphatase is a polyfunc-
tional enzyme and is closely associated with calcification 
[121). Phosphatidyl serine is an acidic phospholipid 
with strong affinity for calcium and has been postulated 
to play a pivotal role in initiation of mineralization [8, 
12, 120). Moreover, proximal tubular brush border is 
one of the single largest membrane pool in mammalian 
kidney [87), and proximal tubular epithelial cells are 
highly susceptible to injury resulting in membrane 
sloughing [112). Thus, the renal brush border mem-
brane can provide a suitable surface for crystal nuclea-
tion in the urinary environment and is a prime candidate 
as a crystal nucleator. Membranuria can be induced by 
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Figure 2 (on the facing page 605). Section through a 
demineralized calcium oxalate monohydrate stone pre-
sent at the renal papillary tip of a rat with nephrolithia-
sis. Cellular degradation products are closely associated 
with the crystal ghosts (single arrows). Double arrows 
mark the cellular degradation products located at a sec-
ondary nucleation site which is at the base of radially 
organized ghosts of monoclinic Ca Ox monohydrate crys-
tals. The stone was first examined by scanning electron 
microscopy and then processed for transmission electron 
microscopy. 
administration of gentamicin sulphate or mercuric chlo-
ride, which affect the proximal tubular epithelial cells 
and low doses of ethylene glycol can be used to induce 
low grade hyperoxaluria to avoid heavy deposition of 
crystals in the kidneys [38). 
In one model, male Sprague-Dawley rats were given 
daily subcutaneous injections of gentamicin sulphate, 100 
mg/kg rat body weight and 0.25% ethylene glycol in 
drinking water [38). One group of rats was given ethyl-
ene glycol only, another gentamicin sulphate only, and 
the third group of rats received both simultaneously. 
Rat urines were collected daily, and examined by light 
microscopy with both bright field and polarized optics. 
Urinary pH was measured. Urinary Ca2+, Na+, K+, 
Mg2 +, ammonium, phosphate, sulphate, citrate and oxa-
late were determined. Using these data, urinary CaOx 
supersaturations were calculated. Kidneys and urinary 
sediments were examined by light, scanning and trans-
mission electron microscopy. With ethylene glycol only, 
no morphological changes were found in the kidneys but 
urinary oxalate levels were elevated. Gentamicin admin-
istration resulted in progressive renal tubular damage 
and an increase in membranous cellular degradation 
products in the urine. Neither ethylene glycol nor genta-
micin alone induced CaOx crystals. However, simulta-
neous administration of the two resulted in CaOx crys-
talluria in all animals by day 4 without overt tubular 
necrosis and crystal deposition in the kidneys. Crystals 
were intimately associated with cellular degradation 
products (Fig. 3). In addition, there was an increase in 
both urinary calcium and oxalate concentrations, as well 
as Ca Ox supersaturation, thereby, increasing the chance 
of crystallization of CaOx. Supersaturation was, how-
ever, not high enough for the homogeneous nucleation 
of crystals. In a separate study, a higher grade of 
hyperoxaluria in association with gentamycin-induced 
membranuria produced CaOx crystal deposition in kid-
neys of 63 % of the rats [71). We propose that membra-
nous cellular degradation products acted as nucleators of 
CaOx in this model. 
Calcium oxalate crystals in mammalian urine 
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Figure 3. Calcium oxalate dihydrate crystalluria parti-
cles in close association with non-crystalline material 
(arrows). Transmission electron microscopy of such 
deposits has revealed the crystals to be associated with 
cellular degradation products [ 46). 
-------------------------
In a second in vivo rat model, membranuria was in-
duced by administration of mercuric chloride which was 
subcutaneously injected into male Sprague Dawley rats 
at a dose of 0.5 mg per kg rat body weight per day. A 
0.25% solution of ethylene glycol in drinking water was 
given as the lithogen. Rats were housed in metabolic 
cages. On days 1, 3, 5, and 7, their urines were exam-
ined by light and scanning electron microscopy. At the 
end of the experiment, rats were sacrificed, and their 
kidneys harvested and processed for light microscopic 
examination using paraffin embedding and hematoxylin 
and eosin (H&E) staining. Three other groups of con-
trol rats: one of normal rats receiving no additives, the 
second with 0.25 % ethylene glycol administration, and 
the third with 0.5 mg per kg rat body weight per day 
mercuric chloride, were also studied along with the 
experimental ones described above. Kidneys from all 
groups of animals were free of crystals. All animals re-
ceiving mercuric chloride displayed membranuria as cel-
lular degradation products in their urine. After 7 doses, 
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Figure 4. Radially organized highly birefringent crys-
tals of CaOx monohydrate formed in vitro in association 
with vesicles of renal proximal tubular brush border 
membrane. 
all rats receiving the combined treatment had CaOx crys-
tals in their urine. Crystals appeared to be associated 
with membranous products. 
Thus, in both the mercuric chloride/ethylene glycol 
and gentamicin sulphate/ethylene glycol models, an in-
crease in urinary oxalate or urinary CaOx relative super-
saturation alone did not result in crystallization of CaOx. 
Only when hyperoxaluria was associated with membrane 
shedding did the crystals form. The membrane shedding 
may be associated with other changes that so far we 
have not studied and which may be involved in crystalli-
zation. But crystal formation in association with cellular 
membranes does indicate some relationship between the 
two and appears to implicate cellular membranes in 
CaOx crystallization. 
Cellular Membranes and Calcium 
Oxalate Crystallization in vitro 
Brush border membrane vesicles isolated from rat 
kidneys, were incubated at a concentration of 0.1 mg 
protein/ml in 0.2 µm filtered, metastable solutions of 
CaOx at 37°C and initial pH of 6.5 for 24, 48, 72 or 96 
hours [62]. The relative supersaturation of the solutions 
was 6.33. After the incubations, solutions were filtered 
through 0.2 µm Nucleopore filters and the precipitates 
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Figure 5. Section through the center of a demineralized human calcium oxalate monohydrate stone after conventional 
staining. The staining shows highly electron dense material (arrows) intimately associated with plate-like ghosts of 
monoclinic CaOx crystals. 
605 
S.R. Khan 
,, ;:,,.. .., -, ~ 
;~\ .. -,, 
• • J 
' \ .. _ 
·\ 
' 
. ..,~ . . . . ---- .- \ .. : " . . ~ .. ~~ ·. ~ 
~ ' " - 1;:-· _ -~ ..... ' a~=-:~:_ -•~ 
__.... ' . • ), .. 
~ .' ~- , -,. 
_ ,..Jo- .. 
' -.- -
,I 
Figure 6. Malachite green staining of demineralized 
calcium oxalate monohydrate stone with (a) and without 
(b) chloroform methanol treatment. The treatment re-
duced the intensity of staining of the matrix material 
indicating a loss of lipidic constituents. 
--------------------------------------
were examined by scanning electron microscopy to iden-
tify the crystals. Depletion of calcium and oxalate in the 
filtrate was determined by atomic absorption spectropho-
tometry and scintillation counting. There was a gradual 
increase in the depletion of calcium and oxalate from the 
metastable solution with a concomitant decrease in CaOx 
relative supersaturation. By 72 hours, there was a 
49. 8 % decrease in calcium, 43 .6 % in oxalate and 60.4 % 
in CaOx relative supersaturation and crystals of CaOx 
were seen associated with the substrate. Drops from 
some of the solutions were examined for birefringence 
by polarizing optics of a light microscope. Aggregates 
of highly birefringent crystals of CaOx were seen in 
close contact with the membrane vesicles (Fig. 4). 
There was no change in the calcium or oxalate level of 
the metastable solution of CaOx incubated without the 
membrane substrate. We concluded that brush border 
membranes can induce CaOx crystallization from a 
metastable solution which would otherwise not undergo 
spontaneous crystal nucleation. 
In constant composition crystallization experiments, 
calcium and oxalate consumption started much earlier 
when brush border membranes were present in the solu-
tion, occurring within 258, 32, or 8 minutes of incuba-
tion in a metastable calcium oxalate solution at relative 
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Figure 7. Chloroform methanol treatment of the demin-
eralized stone disclosed membranous material in the 
electron dense material associated with the crystals. 
-------------------------------------
supersaturations of 6, 10 or 12 respectively [63]. The 
plate-like crystals were formed in association with the 
membrane vesicles. Since crystallization started within 
Calcium oxalate crystals in mammalian urine 
.,. 
·· 8 
8 minutes of the incubation of brush border membrane 
in a CaOx solution of a low relative supersaturation of 
12, there is a distinct possibility that membrane asso-
ciated crystallization of CaOx might occur in the urine 
of stone formers which is known to have a CaOx rela-
tive supersaturation much higher than 12. 
The effect of CaOx urinary stone matrix and its 
lipid contents on in vitro crystallization of CaOx was 
also studied [60]. Incubation of whole matrix or its 
lipids in a metastable solution of CaOx resulted in the 
depletion of calcium and oxalate, a decrease in the CaOx 
relative supersaturation and the formation of CaOx crys-
tals. No calcium or oxalate depletion, or CaOx crystal-
lization was detected in the metastable solution without 
the substrates. 
Cellular Membranes and Lipids in 
Urine and Urinary Stones 
If membranes play a role in crystal nucleation dur-
ing urolithiasis then one should be able to find mem-
branous profiles and their constituent lipids in urine and 
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Figure 8. Membranous profiles (arrows) were seen 
tightly bound to the surface of calcium oxalate crystal 
ghosts after conventional fixation and staining. Inset 
shows the profile of a vesicle. 
urinary stones. Cytochemical examination of decalcified 
human CaOx urinary stones has shown osmiophilic, and 
PAS and colloidal iron positive material in their matrices 
indicating the presence of cellular degradation products 
[51, 61] . Boyce [14, 15] also found osmiophilic mate-
rial in urinary stones but interpreted it as glycoprotein. 
Kim [68] interpreted the osmiophilia of CaOx dihydrate 
as having been caused by lipids associated with the crys-
tals. Transmission electron microscopy of demineralized 
CaOx stones revealed the presence of cellular degrada-
tion products in the intercrystalline spaces [51, 52, 55, 
66]. Furthermore, the presence of lipids in stone matrix 
was confirmed when lipids were isolated from stone 
matrix by biochemical extraction and identified using 
thin layer and column chromatographic techniques [61]. 
All urinary stones, including those composed of CaOx, 
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Figure 9. Section through demineralized, partially de-
mineralized and intact calcium oxalate crystals. Staining 
of intact crystals is denser than that of the demineralized 
crystals. 
-------------------
struvite and uric acid contain some lipids. But calcific 
urinary stones, e.g., calcium oxalate and struvite stones, 
contain more phospholipids than the uric acid stones 
[61] . A number of phospholipids, including phos-
phatidyl ethanolamine, phosphatidyl choline, sphingo-
myelin, phosphatidyl serine, phosphatidyl glycerol and 
cardiolipin have been identified in stone matrices. 
Neutral and glycolipids have also been isolated and ana-
lyzed from a number of CaOx urinary stones and identi-
fied; these include mono-, di-, and triglycerides, sterol 
ester and cholesterol and free fatty acids as neutral lipids 
and sulfatides, galactosyl-di-glycerides, I, II galacto-
cerebroside and glucocerebroside as glycolipids. Thus, 
with respect to the presence of lipids, urinary stone ma-
trix is not different from the matrix of a number of bio-
mineralized substances such as bone, dentine, enamel, 
and various types of salivary calculi. 
Epithelial cells are continuously sloughed and ex-
creted by both normal human males and females, 78,000 
cells/hour by males and 68,000 cells/hour by females, 
supplying cellular membranes to the urine [89]. Bio-
chemical analysis discloses that urine from stone formers 
contain more and different phospholipids than the urine 
from normal humans [122] . 
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Figure 10. Section through demineralized calcium oxa-
late crystals induced in whole human urine by adding so-
dium oxalate. Cellular degradation products are present 
in the intercrystalline areas. 
---------------------------
Localization of lipids in matrices of calcium oxalate 
stones 
To better understand the role of lipids and mem-
branes in stone formation, we cytochemically localized 
lipids in stones. Because most lipids are easily lost dur-
ing processing for electron microscopy, a newly devel-
oped technique using malachite green (MG) during fixa-
tion was utilized [35]. Fragments of urinary stones 
comprising mainly of CaOx monohydrate were deminer-
alized by treatment with a mixture of Kamovsky's fixa-
tive and 0.25 M ethylenediaminetetraacetic acid (EDTA) 
[53, 54] . Following demineralization, the specimens 
were stained with 0.1 % MG in 2 % glutaraldehyde and 
postfixed in 1 % osmium tetroxide. Control specimens 
were fixed without MG. The specimens were then de-
hydrated, embedded in Spurr's plastic, sectioned and 
examined using a Zeiss 10 transmission electron micro-
scope. In addition, a few specimens were first treated 
with chloroform methanol and then stained with MG. 
Demineralization resulted in the disappearance of 
crystals and the formation of crystal ghosts (Fig. 5). 
Both control and MG stained stone sections demon-
strated the presence of electron dense osmiophilic mate-
rial in close contact with the crystal ghosts. But MG 
Calcium oxalate crystals in mammalian urine 
stained sections (Fig. 6a) showed much more intense 
staining which disappeared after chloroform methanol 
treatment (Fig. 6b), indicating its lipidic nature. 
Chloroform methanol treatment also revealed the pres-
ence of membranous profiles in the electron dense mate-
rial associated with the crystals (Fig. 7). 
Profiles of membranous vesicles were seen tightly 
bound to the surfaces of crystal ghosts (Fig. 8). Sec-
tions through partially demineralized crystals showed 
that staining of intact crystals was much more dense than 
that of the demineralized crystals (Fig. 9). It is well 
known that demineraliz.ation is necessary for total extrac-
tion of phospholipids from mineralized tissues [9]. Prior 
demineraliz.ation was also shown to increase the yield of 
phospholipids from calcific urinary stones [61]. 
Crystal induction in human urine 
Calcium oxalate crystals were induced in whole 
human urine by adding sodium oxalate at 37°C in a 
shaker water bath as described earlier [110]. After 3 
hours of incubation, crystals were harvested by centrifu-
gation at 10,000 g for 30 minutes. Crystals were iden-
tified by X-ray diffraction and scanning electron 
microscopy. They were washed with distilled water, 
demineralized, and processed for transmission electron 
microscopy [54, 55]. Lipids were extracted and isolated 
from the crystals using chloroform methanol and identi-
fied using thin layer chromatographic techniques [61]. 
Crystals were mostly that of CaOx monohydrate and 
demineraliz.ation resulted in the generation of crystals 
ghosts (Fig. 10). Cellular degradation products were 
found closely affiliated with the crystal ghosts. A 
variety of lipids including phospholipids, glycolipids, 
and neutral lipids were identified in crystal matrices 
(Khan et al., submitted for publication). 
Concluding Remarks 
It is now generally acknowledged that crystal nucle-
ation in the urine is heterogeneous. What is still debated 
is the nature of the nucleating substrate or substrates. 
Since many substances found in urine have been shown 
to be capable of nucleating calcific crystals in vitro, pos-
sibility exists for the presence of more than one type of 
nucleators in the urine. Nucleating potential of the sub-
strate is most probably influenced by the urinary condi-
tions. Most crystalliz.ation studies in vitro are carried 
out in inorganic solutions or urine. One should, how-
ever, be careful about extrapolating results of in vitro 
studies in inorganic solutions to in vivo conditions in the 
kidneys. The physiological, hydrodynamic and physico-
chemical environment of the kidney cannot be repro-
duced. Even the studies carried out in human urine may 
result in erroneous interpretations. There are many 
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problems associated with using excreted urine. First, 
human urine used in crystalliz.ation studies is actually 
bladder urine which is different from the urine present 
in kidney tubules where kidney stones form [26]. It is 
well established that urine produced at the glomerulus 
undergoes several changes when it passes through vari-
ous segments of the renal tubules. Along with many 
ions, water is reabsorbed changing the ionic concentra-
tion of the urine with obvious impact on relative super-
saturation of various stone forming salts. Macromole-
cules like Tamm-Horsfall protein, nephrocalcin and os-
teopontin are secreted and added to the urine, again with 
obvious repercussions for crystalliz.ation. In addition, 
many more macromolecules may be added when the 
urine reaches the bladder [26]. Thus, urinary environ-
ment in the earlier segments of the renal tubules is very 
different from the one in later segments and different 
still from the bladder urine. Crystals that initiate stone 
formation may form as early as the loop of Henle [21]. 
Secondly, urine goes through many processing steps, 
such as filtration, centrifugation, ultrafiltration, dilution 
and lyophiliz.ation before being utilized for the studies. 
Depending on such factors as: the pore size of the filter 
paper, speed and length of centrifugation, and molecular 
weight cut off during ultrafiltration, membranous cellu-
lar degradation products as well as many normally and 
abnormally occurring macromolecules will be lost during 
the processing. This will certainly influence crystalliz.a-
tion. Consequently, the study of crystal nucleation in 
excreted bladder urine may not be entirely relevant to 
what happens during kidney stone formation in vivo. 
Still, the studies performed in vitro in inorganic solu-
tions or urine, provide some insight into crystalliz.ation 
processes, but results must be interpreted judiciously and 
supported by studies in vivo in animal models. 
Many of the normally occurring, well characterized 
urinary macromolecules such as: osteopontin, nephrocal-
cin, prothrombin fragment 1, urinary bikunin (uronic 
acid rich protein), and Tamm-Horsfall protein are cur-
rently considered inhibitors of CaOx crystalliz.ation. It 
is possible that some of these, once adsorbed on an ex-
isting surface, such as a growing stone, may promote 
further crystalliz.ation and stone growth. 
CaP has been considered a nucleator because it is 
present in almost all urinary stones, it is common in 
urine, and can promote nucleation of CaOx in vitro. 
Recent studies have indicated that urinary CaP super-
saturation in the loop of Henle is high enough to support 
nucleation of calcium phosphate crystals. These CaP 
crystals can then nucleate CaOx crystals when they 
reach the collecting ducts where urine is supersaturated 
with respect to CaOx. In the animal model, however, 
CaOx crystals did not deposit on the surfaces of CaP 
crystals. 
S.R. Khan 
Evidence has been provided here that: (1) membra-
nous cellular degradation products are always present in 
urine and urinary stones; (2) in experimental animal 
models, renal crystal deposits are invariably associated 
with membranous cellular degradation products; and (3) 
cellular membranes can induce nucleation of CaOx crys-
tals from a metastable solution in vitro and the metasta-
ble urine in vivo. In addition, while CaP and other crys-
tals must themselves be formed before they can act as a 
substrate for CaOx crystallization, membranous vesicles 
are ubiquitous in urine as a natural byproduct of renal 
epithelial cell turnover. 
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Discussion with Reviewers 
G.H. Nancollas: The micrographs certainly show some 
interesting juxtapositioning of phases, but it will be 
important to know whether the author was able to con-
firm the inorganic and organic phases either by energy 
dispersive X-ray microanalysis (EDX) or through the 
TEM, by electron diffraction for the mineral phases. 
This would make the argument concerning the nucleation 
of crystallites at the surfaces of cellular degradation 
products much more compelling. The characterization 
of crystal ghosts following demineralization will be of 
particular interest. 
Author: Both crystalline and organic phases were ana-
lyzed by EDX. An analysis of demineralized CaOx 
crystals and their associated matrix by EDX disclosed 
the absence of both calcium and phosphorus. As is gen-
erally known, and I have pointed out in this paper and 
others, CaP phase is often seen in association with CaOx 
crystalline deposits. But many of the stone fragments 
chosen for this study did not contain CaP crystals and 
the matrix material associated with CaOx crystals was 
negative for calcium and phosphorus, both before and 
after demineralization. Transmission electron micros-
copy of demineralized stones also did not reveal CaP 
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ghosts in places where CaOx crystal ghosts were abut-
ting the membranous cellular degradation products. 
However, it does not mean that all three cannot be found 
together. I am sure that, at places, they do occur to-
gether, because CaP and CaOx crystals often co-exist in 
a stone. Both CaP crystals and membranes were found 
capable of nucleating CaOx crystals in vitro. But in 
vivo, only the membranous vesicles were seen associated 
with CaOx crystals. EDX did not reveal the presence of 
phosphorus in association with the CaOx crystals. 
A. Boskey: Which do you think comes first in vivo -
membrane degeneration leading to crystal nucleation or 
the presence of crystals to cell breakdown. Is there 
proof for or against your answer? 
Author: Recent studies by our group as well as others 
have provided evidence that oxalate ions themselves are 
injurious to the cell membranes. There was increased 
excretion of many renal membrane-associated enzymes 
by hyperoxaluric rats [126]. In tissue culture experi-
ments [124], MDCK (Madin-Darby canine kidney) cells 
exposed to low concentrations of oxalate demonstrated 
a loss of cell to cell contact, decreased cell viability, and 
adherence to the substrate. There was an increase in ad-
enine release as well as many membrane-associated en-
zymes into the culture medium. Exposure of LLC-PKl 
cells, another renal epithelial cell line, to oxalate also 
resulted in cell injury [130]. Thus, hyperoxaluria that 
generally precedes CaOx nephrolithiasis can by itself 
induce degenerative changes in the membranes of the 
epithelial cells lining renal tubules. 
A. Boskey: Do you not think that Selye's calciphylaxis 
model is another illustration of membrane associated 
calcification? 
Author: Calcium phosphate crystal formation during 
calciphylaxis may very well be membrane associated. 
A. Boskey: How much of a contribution does calcium 
and lysosomal enzyme release from dying cells con-
tribute to the lipid induced calcification? 
Author: In the case of CaOx nephrolithiasis, urinary 
oxalate plays a more important role than urinary calci-
um. Urine from both normal humans and rats is inhibi-
tory to growth of CaOx crystals. However, in an exper-
imental study, urine from rats with renal cellular injury 
was significantly less inhibitory to CaOx crystal growth 
[123]. 
W. Achilles: How would you explain your findings that 
male rats are prone to form CaOx while females tend to 
form CaP stones? Was there a significant difference in 
urine composition of both sexes? 
Author: There were no significant differences in uri-
Calcium oxalate crystals in mammalian urine 
nary chemistries of male and female rats. Interestingly 
enough, male hyperoxaluric rats produced aggregated 
CaOx crystals while female rats produced single crys-
tals. Since aggregated crystals have a better likelihood 
of retention within the nephron, it is possible that there 
are differences in urinary crystal aggregation inhibitors 
between males and females. 
Sex hormones may also be involved. Lee et al. 
[127] assessed the role of testosterone in CaOx nephro-
lithiasis. 0.5 % ethylene glycol was administered in 
drinking water to male and female, intact and castrated 
Sprague-Dawley rats. All rats became hyperoxaluric. 
All 7 intact male rats had CaOx crystal deposits in their 
kidneys and five of them produced stones. Only 2 of 7 
castrated males had CaOx crystal deposits in their kid-
neys and only one of them produced a stone. None of 
the female rats, intact or castrated, produced CaOx stone 
and only 2 of 7 in each group had small amounts of 
CaOx crystals in their kidneys. 
W. Achilles: The term cellular degradation products 
(CDP) comprises a great variety of chemically and phys-
ically different compounds. Can you specify which class 
of substrates or moieties are most likely to act as crystal 
nucleators? 
Author: According to the current concepts, it is the 
phospholipids of cellular membranes that are involved in 
nucleation of calcific crystals. 
W. Achilles: Is there any evidence for potential role of 
CDP in crystal aggregation also, or do you think that 
CDP are only of importance in nucleating crystals? 
Author: According to Mandel [129] and Lieske et al. 
[ 128] cellular membranes of injured renal epithelial cells 
can bind CaOx crystals. Transmission electron micro-
scopic studies of CaOx ministones produced by hyper-
oxaluric rats showed that crystals aggregated together by 
entrapment within a meshwork of membranous cellular 
degradation products [53] . Another study showed crys-
tal retention within an injured rat urinary bladder by be-
ing trapped in a mass of cellular degradation products 
[126]. Thus, CDP can bind the crystals and help in 
their aggregation and retention within the kidneys. 
W. Achilles: If CDP were causative in stone formation, 
stone formers should have a higher rate of tubular cell 
destruction and more cellular debris in their urine. Can 
you confirm this? 
Author: I really do not have a good answer. Nobody 
to my knowledge has looked into this. It may not be 
necessary to have more CDP's in stone formers urine. 
They may just have more of those lipids, like many 
phospholipids, that are involved in crystallization. Or, 
perhaps, the lipids of cellular membranes in kidney stone 
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formers renal epithelial cells are organized differently so 
head groups involved in crystal nucleation and binding 
are properly oriented for these activities. We found that 
urine of stone formers have more acidic phospholipids 
than the urine of non stone formers (unpublished). 
Here a distinction should be made between crystal 
formation and stone formation. Under normal condi-
tions, crystals nucleate and stay separate, easily passing 
through the nephron and excreted with the urine. In a 
pathological situation, on the other hand, there may be 
more lipids and membranes or membranes with properly 
aligned lipids that may bridge crystals together and pro-
mote crystal aggregation and their retention within the 
kidneys. 
W. Achilles: Are the phospholipids found in urine con-
stituents of kidney CDP or do they come from blood by 
glomerular filtration? 
Author: Urinary phospholipids excreted by kidneys 
with normal glomerular function are, most probably, of 
renal cellular origin. 
R. Ryall: The author describes studies demonstrating 
that lipids can induce precipitation of CaOx from inor-
ganic solutions in vitro. These will not reflect events 
occurring in urine and may not be relevant in vivo. Is 
there any evidence that lipids can induce CaOx crystalli-
zation in human urine? 
Author: Actually, I have discussed results of both in 
vitro and in vivo studies and have demonstrated that 
membranes and lipids promote CaOx crystallization in 
both inorganic solutions and urine. As I discussed in the 
paper, CaOx crystals were induced in vitro in inorganic 
solutions of low CaOx supersaturation by incubating 
brush border membrane vesicles derived from renal 
proximal tubular epithelium. CaOx crystals were also 
induced in vivo in the urine of hyperoxaluric rats by 
experimental induction of membranuria. I have not per-
formed any in vitro studies using human urine. This 
matter has been discussed in detail in Concluding 
Remarks. 
R. Ryall: When does a urinary macromolecule become 
a "cellular degradation product", rather than a normal 
filtered or secreted component of urine? 
Author: It is a cellular degradation product when asso-
ciated with injured, dying or dead cells. Cellular degra-
dation products occur normally in the urine since older 
cells of the renal epithelium are continuously being re-
placed by new ones. Of course, membranous material 
will not be a filtered component of the urine. Obvious-
ly, membranous substrates which can possibly nucleate 
calcific crystals are abundant in the urine. Perhaps, it 
is why the urine contains so many inhibitors of crystalli-
S.R. Khan 
zation; an evolutionary response to the abundance of 
promoters therein. 
R. Ryall: How do you know that the crystal associated 
substances are cellular degradation products? 
Author: By microscopic examination of H&E stained 
light microscopic slides and transmission electron 
microscopy. This does not, however, mean that there 
were no normally occurring substances associated with 
the crystals. 
R. Ryall: Does malachite green bind to CaOx crystals? 
Author: I do not know whether inorganic CaOx crys-
tals bind the dye. However, Ca Ox crystals present in 
the urine and urinary stones are always coated with an 
organic substance, and thus, inorganic surface may not 
be available for binding. 
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